Singapore, Oct. 30 -- Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.73 billion ($11.6 million)in four R&D projects for the development of diagnostics and a vaccine for tuberculosis (TB), neglected tropical diseases (NTDs), and malaria.

The GHIT Fund is investing JPY 390 million ($2.6 million) in a global partnership aimed at assessing and introducing an innovative TB diagnostic. This project is being led by the United Nations Office for Project Services (UNOPS) hosted organisation Stop TB Partnership, in collaboration with FUJIFILM Corporation, the Liverpool School of Tropical Medicine, and research institutions in Cameroon, Nigeria, and Germany. The investment builds ...